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Summary.- The present study examines the possibility of correlation between free
serum and urinary total hydroxyproline and whether this correlation can be applied
to clinical conditions.
The correlation between the two indices was 0-80 (P<0.001) in 18 patients, mostly
suffering from malignant disease. On comparing the same measurements in 37
patients, all with known metastatic bone disease, we found 29/37 normal results
for free serum hydroxyproline, whereas only 2/37 values of urinary total hydroxy-
proline were normal.
The authors therefore conclude that urinary total hydroxyproline, measured as
the ratio hydroxyproline/creatinine in a fresh specimen of early-morning urine, is
the best index of collagen breakdown in metastatic bone disease and preferable to
measurement of free serum hydroxyproline.
TOTAL URINARY and free serum hy-
droxyproline have been claimed to be
useful for the early diagnosis of metastatic
bone disease (Kontturi et al., 1974;
Powles etal., 1976). Totalurinaryhydroxy-
proline excretion (urinary Hyp) has been
used for the estimation of the efficiency
of a therapeutic regimen on female breast
cancer in the presence of bone metastasis
(Powles et al., 1975). However, it is often
more convenient to collect blood samples
than urine. If free serum hydroxyproline
(serum Hyp) was as efficient as urinary
total hydroxyproline in the diagnosis of
skeletal metastases, it might be therefore
preferred. If however blood samples are
not as good, the ratio of total hydroxy-
proline to creatinine in a fresh morning
urine (Hyp/Cr) is more convenient than
making a 24 h urine collection. This latter
measurement should be made on a con-
stant diet for at least 48 h, while the
Hyp/Cr may be collected after an over-
night fast (Nordin et al., 1976). For these
reasons it is important to know the relative
diagnostic accuracies.
The present studies have been designed
to answer the following questions:
(a) Are the results of urinary Hyp and
free serum Hyp correlated in a given
situation?
(b) Are urinary Hyp and serum Hyp of
equal value in the diagnosis of neo-
plastic bone disease?
MATERIAL AND METHODS
Study A.-Eighteen patients (13 females,
5 males) aged 38-75 years wNere examined
while they were in hospital. Fifteen of them
were suffering from malignant disease; their
diagnoses and the presence or absence of
skeletal metastases are given in Table I.
Skeletal metastasis was identified on the basis
of clinical signs, bone scintigraphy and bone
radiography. The 3 remaining persons were
2 normal controls and 1 with postmenopausal
osteoporosis.
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TABLE I.-Diagno
skeletal metastaser
malignant disease
Diagnosis
Breast carcinoma
Bronchial carcinoma
Melanoma
UJndifferentiated
carcinoma of
undetermined origin
The patients receii
for 48 h. After 24 h
was taken, and an
fresh morning urine v
urine was collected on
patients the study
interval of at least ti
have 28 results for t
Study B.-Thirty-s
18 female) suffering i
origin wereexamined.
bone disease, as shov
hann,. r.zin+.Aorq.nhx7r -q.n
sis and presence of Hansen, 1974). The serum measurement
s of 15 patients with was done after a continuous dialysis. The
examined in Study A urines were hydrolysed at 11000 for 16 h
before the colorimetric reaction. The normal
Number range for serum Hyp in our laboratory is
No. ,3 involvement 9-25±4-24 IuM (22 controls, aged 22-59 No. i
years). The normal range for hydroxyproline
2 0 2 2 excretion, measured as the Hyp/Cr, is 1-82+
11 1 1-16 (37 controls, aged 22-59 years). If
hydroxyproline excretion is measured as the
1 0 1 output per 24 h, its normal values are 197+
126 ,umol/24 h (10 controls, aged 22-35
ved a collagen-free diet years). All values are given as the mean
a fasting blood sample ±2 s.d.
untimed specimen of The coefficients of variation for serum
vas collected. Thereafter Hyp are 2-1% intra-assay and 5% inter-
ver 24 h. In some of the assay, for Hyp/Cr 4.4% intra-assay and
was repeated after an 7.3% inter-assay. Thecoefficients ofvariation
wo weeks. We therefore intra assay were calculated from 10 deter-
he*18 patients. minations, those inter assay were measured Iheven patients.(19 mal in 9 series for total urinary Hyp, and in 17 ;even patients (19 male, seisfrsrmHp from cancer of differentseisfreumHp
Theycal ha metastatic The mean recovery of hydroxyproline
nbheytpallhd letasttio added to urine or serum is the same for both wn by typical lesions O (88%). id /nr 'Y_rn.xr Th,,ir dinro_\ ° llU'LIUllt;iSt;llgl-upily allU/Ul- ,%-r-y. 111IU11 U148-
noses are given in Table II. Their ages varied
from 43 to 87 years.
TABLE II.-Origin of skeletal metastases
in the 37 patients ofStudy B
Breast carcinoma 14
Bronchial carcinoma
(small-cell 1, adenocarcinoma 3, squamous
carcinoma 7) 11
Prostatic carcinoma 4
Hypernephroma 1
Carcinoma of stomach 1
Oesophagus carcinoma 1
Myeloma 1
Colonic carcinoma 1
Carcinoma of undetermined origin 1
Bronchial squamous carcinoma+hypernephroma 1
Breast carcinoma+uterine carcinoma 1
The patients received a collagen-free diet
for 24 h. Thereafter a fasting blood sample
and a specimen of fresh morning urine were
collected.
Chemical methods (Studies A and B)
Blood was allowed to clot for 1 h at room
temperature. Serum was collected and frozen
at -20°C until the analyses were made.
The urine was collected on thymol crystals
at +4°C. It was then acidified with HCI and
stored.
Hydroxyproline was measured by an
automated method (Blumenkrantz & Asboe-
RESULTS
Study A
The results are given in Figs. 1 and 2.
There are good correlations between
serum Hyp and urinary Hyp, measured
either by the 24 h output (r=0-81) or
by Hyp/Cr (r=0-80 in a 24 h urine,
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FIG. 1 Study A. Regression line for 28
measurements of serum Hyp and Hyp/Cr
in a fresh morning urine, collected at the
same time after 24 h on a collagen-free diet.
The broken lines represent the upper limits
of normal. y=0-704x-0-640; r=0-7936;
P=<0-001; n=28.
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FIG. 2 Study A: Regression line for
measurements of serum Hyp and Hy
in a 24 h urine collection, after 24 h (
collagen-free diet. Thebrokenlines repre
the upper limits of normal. y=0-66(
0 033; r=0 7957; P= <0 001; n=28
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FIG. 3-Study B: A. Free serum hydrc
proline in ,LM. The shaded area represf
the normal range (5-19-13-44). B. Urir
Hyp excretion measured as the ratio H
Cr in a fresh morning urine. The resul
calculated as (,tM/mM) x 100. The sha
area represents the normal range (0'
2.98).
r-0 79 in a spot urine). All correlation
coefficients are significant at the 0-001
level.
Study B
The results are given in Fig. 3. There
are only 2/37 normal results for Hyp/Cr
whereas 29/37 serum Hyp values are
normal. The two indices are correlated
(r-0 49, P<0-001).
DISCUSSION
Laitinen (1966) has suggested that
-, 14 ,I - 1) urinary riyp excretion is reiateu to serum
28 Hyp. He observed that both indices
'p/Cr behaved in a similar way. Since the tech-
on a nical precision ofthe serum Hyp measure-
sent ment is better than that of Hyp/Cr, we
,.X undertook the two studies in order to
examine the possibility of replacing the
measurement of urinary Hyp by serum
Hyp. From our results it is clear that,
although there is a good and highly
significant correlation between the two
measures, urinary Hyp is a better dis-
re x 100 criminator between normal and meta-
static disease.
For urinary Hyp the percentage of
raised levels is the same as that published
by Powles et al. (1975) for the same
condition. We cannot confirm the results
* of Kontturi et al. (1974), who found an
earlier response of serum Hyp than of
urinary Hyp in patients with prostatic
cancer with scintigraphic evidence of
skeletal metastases, neither in this study
with various cancer types, or in a study
reported elsewhere, comprising only pro-
y static carcinoma (Jeannet, 1978).
A good correlation between urinary
Hyp, expressed either as its 24 h excretion
+ or as Hyp/Cr in 24 h urine or in a spot
urine has been shown (Powles et al., 1976).
One of these indices may therefore be
)Xy- replaced by the other. We prefer the
ents measurement of Hyp/Cr in a fresh morn-
aypr/ ing urine, since this makes dietary control
It is unnecessary.
Lded We conclude from these results that
although there is a good correlation
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between serum Hyp and urinary Hyp, the
measurement of urinary Hyp in either a
24 h or in a spot urine is of more clinical
relevance. In view of the results reported
elsewhere (Gasser et al., in preparation)
the little (though significant) influence of
collagen intake on Hyp/Cr in a spot urine
makes this parameter the measurement
of choice in screening patients for skeletal
involvement of malignant disease. The
same parameter may be useful for monitor-
ing the effect oftreatment in this group of
patients.
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